Amarin Corp. (AMRN) option implied volatility elevated into sharp rally on release of patient study
Amarin Corp. (NASDAQ: AMRN) September weekly call option implied volatility is at 566, October is at 300; compared to its 52-week range of 35 to 428 into the release of an 8,000 patient study started in 2011 for their omega3 pill Vascepa.
